Thanks very much for those links James and congratulations for getting a mention in the Lancet. I do hope that article results in more people using the Fixhepc route and stimulates discussion in the medical profession about this very important issue. I really think this will be an important milestone.
RSF
G3a. Probably infected 40 years ago.
Diagnosed July 2015
7/7/2015: ALP 69, ALT 209, WBC 5.8, VL 40,000. Fibroscan 9.5 Kpa.
Commenced treatment Sof/Dac (Natco Pharma) 24 wks in Feb 16
VL UND @ 4 wks, 12 wks
EOT 6/7/16
SVR 12
SVR 24
PHEW! Thank you so much Dr James, Monkmeds and all at Fixhepc
.